Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2034061

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2034061

Live Cell Encapsulation Market, By Polymer Type, By Application, By Method, By Cell Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

PUBLISHED:
PAGES: 348 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

Live Cell Encapsulation Market size was valued at US$ 308.77 Million in 2025, expanding at a CAGR of 4.09% from 2026 to 2033.

Live Cell Encapsulation is a biomedical method under which living cells are enclosed within a protective semi-permeable material, such as alginate, hydrogel, and polymer-based microcapsules, creating a selective defensive barrier that allows oxygen, nutrients, and therapeutic molecules to pass while helping shield the cells from immune reactions and external stress. In the global context, growth in this market is supported by government-supported regenerative medicine initiatives and robust cell-therapy regulatory infrastructure. Across the United States, through FDA cellular and gene therapy framework supports growth of cell-based and biomaterial therapies, at the same time NIH-backed generative programs promote translational research support. This supportive scientific and policy environment, along with growing use across ophthalmology, neurology, tissue engineering, and chronic disease care, keeps live cell encapsulation increasingly relevant within the wider healthcare innovation ecosystem.

Live Cell Encapsulation Market- Market Dynamics

Increasing chronic disease burden to encourage cell-based therapeutic adoption

The escalating impact of chronic illnesses is becoming a major reason for growth in the Live Cell Encapsulation market, as these conditions often require long-term, localized, and continuous treatment support. Diseases such as diabetes, degenerative eye disorders, neurological damage, and tissue degeneration need therapies that can remain active in the body for extended periods, which makes encapsulated live-cell systems highly relevant.

A strong government-backed indicator comes from the U.S. Centers for Disease Control and Prevention (CDC), which states that three in four American adults live with at least one chronic condition, while over half live with two or more. This rising treatment burden naturally increases the need for protected cell-delivery platforms that can provide stable therapeutic release over time. Globally, the World Health Organization (WHO) reported that noncommunicable diseases caused millions of deaths in 2021, highlighting the growing worldwide need for durable advanced therapies.

Live Cell Encapsulation Market- Segmentation Analysis:

The Global Live Cell Encapsulation Market is segmented on the basis of Polymer Type, Application, Method, Cell Type, End User, and Region.

Based on polymer Type, alginate likely to be a key segment, because it offers a well-calibrated balance of tissue compatibility, gentle cell protection, and easy nutrient diffusion, that are highly feasible for long-duration cell viability. An illustrative company cases are Austrianova, the company developed a next-generation encapsulation platform in the industry are continue to be built around alginate or alginate variants, reviling its nonstop practical relevance in therapy design. Neurotech Pharmaceuticals, whose encapsulated retinal therapy platform demonstrates gentle biomaterials enables sustained therapeutic release. This positions alginate as a practical choice for maintaining cell viability, providing immune protection, and enabling smooth nutrient and therapeutic molecule exchange.

Classification by method, microencapsulation is anticipated to play a central role, as it delivers an optimal balance of cell protection, nutrient permeability, and scalable therapeutic delivery. This method wraps living cells inside very small protective capsules which allows nutrients and oxygen to pass through and helping the cells stay healthy and protected from immune reactions. Its key strength lies in enabling uniform capsule size, gentle implantation, optimized oxygen diffusion and therapeutic molecules, diabetes specific, regenerative medicine, and ophthalmic applications. Scientific literature consistently notes that microencapsulation has been the most frequently used cell encapsulation approach, reinforcing its continued relevance. A valuable example comes from Sphere Bio (formerly Sphere Fluidics), having droplet microfluidics platforms boost extremely restrained single-cell droplet generation, aligning with detailed microcapsule operational workflows. This creates a microencapsulation suitable for preserving cell function, enabling controlled nutrient exchange, and ensuring consistent capsule structure for reliable therapeutic use.

Live Cell Encapsulation Market- Geographical Insights

From a regional standpoint, North America and Europe remain highly important for live cell encapsulation development due to their supportive regulatory frameworks and established biomaterial innovation ecosystems.Focusing on North America, according to the U.S. National Institutes of Health (NIH) continues to underpin regenerative medicine through its grants and research infrastructure, while the U.S. FDA offers clear approval pathways for advanced cell-based therapies, which helps guide new treatments from research stages to clinical use. This encapsulated cell technologies supports and make easier to move safely from laboratories into real patient care. Companies such as Neurotech Pharmaceuticals and AstraZeneca have recently strengthened confidence through encapsulated retinal implants and cell-therapy platform acquisitions, respectively, reflecting how company-level innovation aligns with public science systems.

Also, Europe stands as a similarly vital region because of the European Medicines Agency (EMA) framework for advanced therapy medicinal products, Horizon-linked research programs, and strong biomaterial engineering capabilities across Germany, the UK, and Switzerland. This combination of policy support, clinical infrastructure, and specialized companies strengthen both regions highly relevant for long-term Cell Type translation and therapeutic acceptance.

.

U.S Live Cell Encapsulation Market- Country Insights

The United States offers a highly supportive environment for Live Cell Encapsulation technologies, supported by strong public science systems and therapy-focused companies. According to the National Institutes of Health (NIH) remains a corner stone, with the Regenerative Medicine Innovation Project authorized at USD 30 million over four years under the 21st Century Cures Act, helping accelerate adult stem cell and biomaterial-based clinical research. Parallelly U.S. FDA's formal framework for regenerative medicine products offers clear pathways for cell therapies, tissue products, and combination biomaterial systems, which directly supports encapsulation-based innovation. Across the organization, Neurotech Pharmaceuticals offers a simple real-world example of how cell encapsulation is being used in medicine, especially for eye-related treatments. Its Cell Type places living therapeutic cells inside a small protective implant that can stay in the eye and release helpful treatment over time, making the approach easier to understand as a long-lasting cell-based therapy solution.

Live Cell Encapsulation Market- Competitive Landscape:

A well-aligned business framework is emerging in live cell encapsulation through collaborations among biomaterial companies, device engineers, and precision cell-delivery technology participants. Firms such as Merck KGaA, ViaCyte, Living Cell Technologies, Sigilon Therapeutics, and Sphere Fluidics are strengthening their presence through better biomaterial design, device refinement, and therapy-linked collaborations. Their efforts are centered on realistic applications in diabetes care, eye therapies, regenerative medicine, and long-duration cell support systems, assisting the field move steadily from scientific development toward broader clinical usefulness.

A few examples are in March 2025, when AstraZeneca decided to purchase EsoBiotec to deepen its in-body cell therapy delivery capabilities, accompanying future encapsulated therapy innovation and parallelly Alcon acquired a majority ownership in Aurion Biotech, supporting ophthalmology-focused cell therapy development and supporting advanced corneal treatment innovation. Developments show that established healthcare groups are associating with specialized encapsulation technologies to expand practical treatment applications and future clinical opportunities. These progressions reflect steady industry alignment toward specialized encapsulation platforms to support broader therapeutic applications and future clinically relevant treatment opportunities.

Recent Developments:

In March 2026, the ISCT 2026 Dublin partner ecosystem showcased deeper partnerships across therapeutic developers, device manufacturers, manufacturing platforms, and reagent suppliers. While not a single M&A event, this reflects the broader strategic direction of the market: cross-functional alliances designed to accelerate cell encapsulation translation from R&D to clinical deployment. This indicates that partnership-driven collaboration is steadily accelerating the shift of cell encapsulation technologies from research stages toward practical clinical use.

In January 2026, Biopharma firms expanded automated microfluidic manufacturing collaborations. These collaborations are helping improve capsule uniformity, sterility control, and scalable dose manufacturing, making encapsulated cell therapies more commercially practical for larger patient populations. This is increasingly relevant for CDMOs and advanced therapy manufacturing alliances. This highlight growing industry focus on scalable, sterile, and standardized capsule manufacturing to support wider clinical adoption and future commercial therapy expansion.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVE CELL ENCAPSULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ViaCyte, Inc.
  • Living Cell Technologies Limited
  • Sigilon Therapeutics, Inc.
  • Sernova Corp.
  • PharmaCyte Biotech, Inc.
  • Merck KGaA
  • AUSTRIANOVA
  • Sphere Fluidics Ltd.
  • Blacktrace Holdings Ltd. (Dolomite Microfluidics)
  • BIO INX
  • Isogen
  • Diatranz Otsuka Ltd.
  • Neurotech Pharmaceuticals, Inc.
  • Beta-O2 Technologies Ltd.
  • TheraCyte, Inc.
  • Others

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE- MARKET ANALYSIS, 2020 - 2033

  • Natural Polymers
  • Alginate
  • Chitosan
  • Cellulose
  • Synthetic Polymers

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Drug Delivery
  • Tissue Engineering
  • Regenerative Medicine
  • Biological Research
  • Others

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY METHOD- MARKET ANALYSIS, 2020 - 2033

  • Microencapsulation
  • Macroencapsulation
  • Nanoencapsulation

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY CELL TYPE- MARKET ANALYSIS, 2020 - 2033

  • Islet Cells
  • Stem Cells
  • Immune Cells
  • Hepatocytes
  • Neural Cells

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical companies
  • Research laboratories
  • Hospitals & specialty clinics
  • Academic institutes
  • CDMOs / cell therapy manufacturers
  • Others

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA
Product Code: ANV6405

Table of Contents

1. Live Cell Encapsulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Live Cell Encapsulation Market Snippet by Polymer Type
    • 2.1.2. Live Cell Encapsulation Market Snippet by Application
    • 2.1.3. Live Cell Encapsulation Market Snippet by Method
    • 2.1.4. Live Cell Encapsulation Market Snippet by Cell Type
    • 2.1.5. Live Cell Encapsulation Market Snippet by End User
    • 2.1.6. Live Cell Encapsulation Market Snippet by Country
    • 2.1.7. Live Cell Encapsulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Live Cell Encapsulation Key Market Trends

  • 3.1. Live Cell Encapsulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Live Cell Encapsulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Live Cell Encapsulation Market Opportunities
  • 3.4. Live Cell Encapsulation Market Future Trends

4. Live Cell Encapsulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Live Cell Encapsulation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Live Cell Encapsulation Market Landscape

  • 6.1. Live Cell Encapsulation Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Live Cell Encapsulation Market - By Polymer Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Polymer Type, 2025 & 2033 (%)
    • 7.1.2. Natural Polymers
      • 7.1.2.1. Alginate
      • 7.1.2.2. Chitosan
      • 7.1.2.3. Cellulose
    • 7.1.3. Synthetic Polymers

8. Live Cell Encapsulation Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Drug Delivery
    • 8.1.3. Tissue Engineering
    • 8.1.4. Regenerative Medicine
    • 8.1.5. Biological Research
    • 8.1.6. Others

9. Live Cell Encapsulation Market - By Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Method, 2025 & 2033 (%)
    • 9.1.2. Microencapsulation
    • 9.1.3. Macroencapsulation
    • 9.1.4. Nanoencapsulation

10. Live Cell Encapsulation Market - By Cell Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Cell Type, 2025 & 2033 (%)
    • 10.1.2. Islet Cells
    • 10.1.3. Stem Cells
    • 10.1.4. Immune Cells
    • 10.1.5. Hepatocytes
    • 10.1.6. Neural Cells

11. Live Cell Encapsulation Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Biopharmaceutical companies
    • 11.1.3. Research laboratories
    • 11.1.4. Hospitals & specialty clinics
    • 11.1.5. Academic institutes
    • 11.1.6. CDMOs / cell therapy manufacturers
    • 11.1.7. Others

12. Live Cell Encapsulation Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Live Cell Encapsulation Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Live Cell Encapsulation Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Denmark
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Denmark Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Denmark Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Denmark Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.19. Rest of Europe
      • 12.3.19.1. Overview
      • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.3.19.6. Rest of the Europe Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Live Cell Encapsulation Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Taiwan
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Taiwan Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Taiwan Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Taiwan Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.18. Vietnam
      • 12.4.18.1. Overview
      • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.18.3. Vietnam Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.18.5. Vietnam Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.18.6. Vietnam Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.19. Rest of APAC
      • 12.4.19.1. Overview
      • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.19.3. Rest of APAC Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.19.5. Rest of APAC Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.4.19.6. Rest of APAC Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Live Cell Encapsulation Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Live Cell Encapsulation Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Iran
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Iran Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Iran Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Iran Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.16. Qatar
      • 12.6.16.1. Overview
      • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.16.3. Qatar Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.16.5. Qatar Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.16.6. Qatar Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.17. Rest of MEA
      • 12.6.17.1. Overview
      • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.17.3. Rest of MEA Market Size and Forecast, By Polymer Type, 2020 - 2033 (US$ Million)
      • 12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.17.5. Rest of MEA Market Size and Forecast, By Method, 2020 - 2033 (US$ Million)
      • 12.6.17.6. Rest of MEA Market Size and Forecast, By Cell Type, 2020 - 2033 (US$ Million)
      • 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Live Cell Encapsulation Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. ViaCyte, Inc.
    • 13.2.2. Living Cell Technologies Limited
    • 13.2.3. Sigilon Therapeutics, Inc.
    • 13.2.4. Sernova Corp.
    • 13.2.5. PharmaCyte Biotech, Inc.
    • 13.2.6. Merck KGaA
    • 13.2.7. AUSTRIANOVA
    • 13.2.8. Sphere Fluidics Ltd.
    • 13.2.9. Blacktrace Holdings Ltd. (Dolomite Microfluidics)
    • 13.2.10. BIO INX
    • 13.2.11. Isogen
    • 13.2.12. Diatranz Otsuka Ltd.
    • 13.2.13. Neurotech Pharmaceuticals, Inc.
    • 13.2.14. Beta-O2 Technologies Ltd.
    • 13.2.15. TheraCyte, Inc.
    • 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!